Week 11 Dyslipidemia Flashcards
Where does cholesterol come from?
synthesized by the liver
additional from diet
membrane structure
What is the precursor to steroid hormones?
cholesterol
What is included in total cholesterol?
LDL-C
HDL-C
VLDL-C
What is the “bad” cholesterol? why?
LDL-C (low density lipoproteins)
promotes plaque development
What is the “good” cholesterol? why?
HDL-C (high density lipoproteins)
protective against plaque development
What the the category of triglycerides?
VLDL-C
What is the optimal level of LDL-C?
<100 mg/dL
What is “high” LDL-C?
160-189
What is the ACC/AHA recombination for pts with LDL-C >190?
high intensity statin to the goal of <100
+ or - ezetimibe and PCSK9 inhibitor
What are common causes of secondary dyslipidemia? (5)
diabetes hypothyroidism obstructive liver disease chronic renal failure drugs that raise LDL and lower HDL (progestins, anabolic steroids and corticosteroids)
What are the therapeutic lifestyle changes in LDL-C lowering therapy? (3)
TLC diet
weight reduction
increased physical activity
What are the 2 criteria of TLC diet?
restrict intake of cholesterol raising nutrients (sat fats <7% of total) and dietary cholesterol
LDL lowering therapeutic options (plant stannous/sterols 2g daily) and viscous fiber (10-25g/day)
What is the lipid lowering drug of choice for tc of hyperlipidemia and for prevention in most pts?
statins
Why are statins the #1 for hyperlipidemia?
reduced the risk of first cardiovascular event and death in pts at increased risk for atherosclerotic cardiovascular disease (ACSVD)
decrease the risk of major coronary events and death in pts with ACSVD
Addition of what can reduce the risk of secondary cardiovascular events?
ezetimibe
What can be added to a statin to reduce LDL-C levels much more than a statin alone and can reduce the risk of CV events?
PCSK9 inhibitor
What else besides ezetimibe and PCSK9 shows limited evidence that it may reduce the risk of CV events when added to a statin?
bile acid sequestrants
What is the only fibrate has demonstrated beneficial events on CV outcomes but its use with statins can increase the risk of myopathy and NOT recommended?
gembribrozil
Is there convincing evidence that adding an extended-release niacin to a statin to increase CV outcomes?
NO
What reduced the risk of ischemic CV event in patients with hypertiglyceridemia and CV risk factors in one random controlled trial?
Icosapent ethyl, an omega 3 polyunsaturated fatty acid
What are statins?
HMG CoA Reductase Inhibitors
How much do statins lower LDL-C?
18-55%
How much do statins lower TG levels?
7-30%
How much do statins raise HDL-C levels?
5-15%
What are the major side effects of statins?
myopathy (increased CK)
Increased liver enzymes (AST/ALT)
What are contraindications to statins?
absolute: liver disease
relative: certain drugs
What are the demonstrated therapeutic benefits of statins? (5)
reduce major coronary events reduce CHD mortality reduce procedures (PCTA/CABG) reduce stroke reduce total mortality
What is the MOA of statins?
block rate-limiting step in cholesterol synthesis
(HMG-CoA to Mevalonic acid Blocked) decreases hepatic cholesterol